The Cooper Companies, Inc. (NASDAQ: COO) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $11.5B. The Maz Rating grades it against the other companies in its sector.
The Cooper Companies, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $60.72, The Cooper Companies, Inc. trades at 20.8x trailing earnings, 2.7x sales and 1.4x book value, with an EV/EBITDA of 15.3. Over the last twelve months it generated about $4.2B of revenue and $556M of net income. It runs a gross margin of 63.6%, an operating margin of 12.9% and a net margin of 13.5%. It shows return on equity of 6.9%, return on invested capital of 4.8% and a free cash flow yield of 5.9%. On the balance sheet: a debt-to-equity ratio of 0.31 and a current ratio of 1.22. Over the past 52 weeks the share price ranged from $51.01 to $89.83, with a beta of 0.82.
The Cooper Companies, Inc. does not currently pay a dividend.
28 Wall Street analyst ratings cover the stock: 14 Buy, 13 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of July 2026, The Cooper Companies, Inc. (COO) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 21.3% / 30% · (Cash+Inv) / Mkt Cap (36m) 1.29% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 21.3% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 1.29% / 33% · Receivables / Mkt Cap (36m) 6.60% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 21.3% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 1.29% / 33.33% · Receivables / Mkt Cap (24m) 6.60% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 20.1% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 1.06% / 33.33% · Receivables / Avg Assets (4Q) 6.47% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 20.1% / 33.33% · (Cash+ST Inv) / Total Assets 1.22% / 33.33% · (Cash+Recv) / Total Assets 7.45% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of July 2026, The Cooper Companies, Inc. (COO) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. The Cooper Companies, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
The Cooper Companies, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated July 31, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.